Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

A wolf in sheep's clothing

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Endoscopic Robotic Mitral Valve Surgery

Expanding options to manage traumatic thoracic vascular injuries

“Lead from the front”: Participative leadership

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Pulmonary hypertension in valve disease: A beast of the past?

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

Anthony Lemaire, MD, William R

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

C. Cameron McCoy, MD, Thomas A. D'Amico, MD

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Quality of life outcomes are equivalent after lobectomy in the elderly

Thymic carcinoma outcomes and prognosis: Results of an international analysis Usman Ahmad, MD, Xiaopan Yao, PhD, Frank Detterbeck, MD, James Huang, MD,

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Is surgery for multiple lung metastases reasonable

Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction

Get it right the first time

A randomized comparison of different ventilator strategies during thoracotomy for pulmonary resection Andrew D. Maslow, MD, Todd S. Stafford, MD, Kristopher.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Left sinus of Valsalva aneurysm: Rare disease, rarer presentation

Frozen elephant trunk technique: Ready to get back to the future?

Attachment disorder in thoracoabdominal surgery

Marc Licker, MD, John Diaper, RA

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Innovation in cardiothoracic surgical training

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

The continuing challenge of congenital heart disease in China

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Energized lung resections

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Did you like Terminator 3 better than Terminator 2

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven I. Hanish, MD, John C. Haney, MD, Charles C. Miller, PhD, William R. Burfeind, MD, Douglas S. Tyler, MD, Hilliard F. Seigler, MD, Walter Wolfe, MD, Thomas A. D’Amico, MD, David H. Harpole, MD The Journal of Thoracic and Cardiovascular Surgery Volume 133, Issue 1, Pages 104-110.e2 (January 2007) DOI: 10.1016/j.jtcvs.2006.08.065 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Overall survival by number of preoperative risk factors (n = 1720). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Risk of development of pulmonary metastasis (n = 13,565). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E2 Overall survival for patients with metastatic pulmonary melanoma (n = 1720). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E3 Overall survival by metastasectomy and disease-free interval (n = 414). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E4 Overall survival by metastasectomy and presence of extrathoracic metastasis (n = 1065). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E5 Overall survival by complete resection, incomplete resection, and nonsurgical treatment (n = 1720). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 104-110.e2DOI: (10.1016/j.jtcvs.2006.08.065) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions